Skip to main content
Disadvantage compensation in jobs and studies: Woman researching on laptop

Education & Career: Achieving Disadvantage Compensation

Fair conditions without special privileges: How to apply for adjustments and implement them practically.

Dr. Alfred Stett – CEO Okuvision

Interview: Founding & Vision

Alfred Stett on the journey from neurostimulation to evidence-based care—and what drives Okuvision.

Traveling with RP: Safe on the Road

Traveling with RP: Safe on the Road

From Booking to Boarding – reach your destination relaxed with planning, assistance, and orientation aids.

RP & Mental Health

RP & Mental Health

Why RP is a burden – and what is proven to help: education, support, rehab, and preservation of function. With concrete strategies for everyday life.

EUTB®: Free Counseling on OkuStim® Reimbursement

EUTB®: Free Participation Counseling

Independent, individual, and accessible: EUTB® supports you – including with cost coverage applications for OkuStim® therapy.

Impending blindness is an emergency-like situation

Retroactive reimbursement of OkuStim® for RP

The LSG Lower Saxony-Bremen considers impending blindness in Retinitis pigmentosa (RP) to be an emergency-like situation and obliges a health insurance company to retroactively reimburse the OkuStim®…

RP: Myth Check – What's Really True – Glasses with raindrops

RP: Myth Check – What’s Really True

Concise, clear, evidence-based: We dispel false expectations and show what is possible today.

Preparing for your consultation: 10 questions that really help

Medical consultation: 10 questions that matter

Go in well-prepared, come out clearly informed: This checklist helps you understand findings and together take informed decisions.

Okuvision: Doctor's Consultation – Hands of Patient and Doctor on the Table

Guideline 045/23: Electrostimulation for Retinitis pigmentosa (RP)

DOG, RG, and BVA name electrostimulation as a therapy option for Retinitis pigmentosa and refer to the G-BA trial study.

The OkuStim® therapy was developed for patients with degenerative retinal diseases such as retinitis pigmentosa. It allows you to slow down the progression of the disease. At the heart of the therapy is the OkuStim® system, which enables you to independently stimulate your retina with weak electrical currents at home.